Altimmune, Inc.ALTNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank79
3Y CAGR-2.0%
5Y CAGR+5.9%
Year-over-Year Change
Research and development spending
3Y CAGR
-2.0%/yr
vs +39.8%/yr prior
5Y CAGR
+5.9%/yr
Recent deceleration
Acceleration
-41.8pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $66.43M | -19.2% |
| 2024 | $82.23M | +25.0% |
| 2023 | $65.80M | -6.7% |
| 2022 | $70.54M | -5.4% |
| 2021 | $74.54M | +49.8% |
| 2020 | $49.77M | +180.2% |
| 2019 | $17.77M | -3.8% |
| 2018 | $18.46M | +0.3% |
| 2017 | $18.41M | +280.6% |
| 2016 | $4.84M | - |